Metoprolol Succinate Tablet, Extended Release
NDC Package 67296-1902-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Metoprolol Succinate tablets is a medication a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. This formulation utilizes a tablet, extended release delivery system. Marketed by Redpharm Drug, this product is identified by NDC 67296-1902 and is authorized under FDA application ANDA203894.

Identification & Billing

NDC Package Code
67296-1902-3
Package Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
67296-1902
11-Digit Billing Format
67296190203

Clinical Specifications

Proprietary Name
Metoprolol Succinate
Non-Proprietary Name
Metoprolol Succinate
Substance Name
Metoprolol Succinate
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
METOPROLOL SUCCINATE 50 mg/1
Pharmacologic Class
Usage Information
This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

Regulatory & Marketing

Labeler Name
Redpharm Drug
Product Type
Human Prescription Drug
FDA Application #
ANDA203894
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-07-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67296-1902-3 identifies a specific commercial package of 30 tablet, extended release in 1 bottle of Metoprolol Succinate, a human prescription drug labeled by Redpharm Drug. This tablet, extended release is formulated for oral use and contains metoprolol succinate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Redpharm Drug on June 07, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

How is this Redpharm Drug product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296190203. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67296-1902-3
11-Digit CMS (5-4-2)
67296-1902-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.